These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30877423)

  • 21. Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation.
    Alsidawi S; Price KA; Chintakuntlawar AV; Westin GF; Garcia JJ; Ma DJ; Okuno SH
    Oral Oncol; 2017 Sep; 72():104-109. PubMed ID: 28797445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study.
    Schneider K; Marbaix E; Bouzin C; Hamoir M; Mahy P; Bol V; Grégoire V
    Acta Oncol; 2018 Sep; 57(9):1165-1172. PubMed ID: 29493423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 24. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.
    Tomita M; Ayabe T; Nakamura K
    Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):288-292. PubMed ID: 29049691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unknown primary of the head and neck: A long-term follow-up.
    Lanzer M; Bachna-Rotter S; Graupp M; Bredell M; Rücker M; Huber G; Reinisch S; Schumann P
    J Craniomaxillofac Surg; 2015 May; 43(4):574-9. PubMed ID: 25841309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Mohanti BK; Thakar A; Kaur J; Bahadur S; Malik M; Gandhi AK; Bhasker S; Sharma A
    Head Neck; 2017 Sep; 39(9):1788-1796. PubMed ID: 28586138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
    Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
    PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
    Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
    Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
    Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
    Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients with Pathological Stage IA Lung Adenocarcinoma Following Surgical Resection.
    Kobayashi S; Karube Y; Inoue T; Araki O; Maeda S; Matsumura Y; Chida M
    Ann Thorac Cardiovasc Surg; 2019 Apr; 25(2):87-94. PubMed ID: 30333361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
    Chandrasekara S; Davis S; Thomson P; Haydon A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
    Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
    Chang CL; Yuan KS; Wu SY
    Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery.
    Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
    Head Neck; 2018 Apr; 40(4):728-739. PubMed ID: 29272056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.